You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CISATRACURIUM BESYLATE PRESERVATIVE FREE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cisatracurium Besylate Preservative Free, and what generic alternatives are available?

Cisatracurium Besylate Preservative Free is a drug marketed by Accord Hlthcare, Eugia Pharma, Fresenius Kabi Usa, Hainan Poly, Hengrui Pharma, Sandoz Inc, and Somerset Theraps Llc. and is included in seven NDAs.

The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cisatracurium Besylate Preservative Free

A generic version of CISATRACURIUM BESYLATE PRESERVATIVE FREE was approved as cisatracurium besylate by SANDOZ INC on February 3rd, 2012.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CISATRACURIUM BESYLATE PRESERVATIVE FREE?
  • What are the global sales for CISATRACURIUM BESYLATE PRESERVATIVE FREE?
  • What is Average Wholesale Price for CISATRACURIUM BESYLATE PRESERVATIVE FREE?
Summary for CISATRACURIUM BESYLATE PRESERVATIVE FREE
Drug patent expirations by year for CISATRACURIUM BESYLATE PRESERVATIVE FREE
Pharmacology for CISATRACURIUM BESYLATE PRESERVATIVE FREE

US Patents and Regulatory Information for CISATRACURIUM BESYLATE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 205872-001 Jun 16, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hainan Poly CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 216539-002 Aug 27, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 203182-001 Feb 26, 2015 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Somerset Theraps Llc CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 206791-001 Feb 20, 2019 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.